UK markets open in 20 minutes

LVTX Oct 2024 2.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.10000.0000 (0.00%)
As of 10:54AM EDT. Market open.
Full screen
Previous close1.1000
Open1.1000
Bid0.2000
Ask1.0000
Strike2.50
Expiry date2024-10-18
Day's range1.1000 - 1.1000
Contract rangeN/A
Volume1
Open interest43
  • Globe Newswire

    LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference

    UTRECHT, The Netherlands and PHILADELPHIA, May 30, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” or “Company”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamma-delta (δ2) T cell engagers, today announced that Stephen Hurly, President and Chief Executive Officer of LAVA Therapeutics, will participate in a fireside chat at the Jefferies Global Healthcare Conference. Presentation Details Format: Fireside

  • GlobeNewswire

    LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results

    LAVA-1207 dose escalation progressing in Phase 1/2a trial in prostate cancer, with pembrolizumab combination expected to begin in Q2 2024Received $7.0 million clinical development milestone from Pfizer for PF-08046052 (formerly LAVA-1223) in Phase 1LAVA-1266 on track for Q2 2024 IND submissionStrong balance sheet with cash of $94.6 million supports runway into 2026 UTRECHT, The Netherlands and PHILADELPHIA, May 21, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” “the Compa

  • Globe Newswire

    LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference

    UTRECHT, The Netherlands and PHILADELPHIA, May 06, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” or “Company”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamma-delta (δ2) T cell engagers, today announced that Stephen Hurly, President and Chief Executive Officer of LAVA Therapeutics, will participate in a fireside chat at the Citizens JMP Life Sciences Conference. Presentation Details Format: Fireside